MEDICAL MARIJUANA, INC. HOME

Scientific Research

Medical Marijuana, Inc. Announces State of Mexico’s Historic Purchase of Company’s Cannabis Product for Its Citizens

SAN DIEGO, Aug. 21, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that the State of Mexico’s government has purchased the company’s Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil products from its subsidiary HempMeds Mexico® to treat 11 of its citizens suffering from varying indications including Refractory Epilepsy and Lennox Gastaut-Syndrome. This is the first […]

Restless Legs Syndrome – Medical Marijuana Research Overview

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Affecting as many as one in 10 people […]

Neuroblastoma – Medical Marijuana Research Overview

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Neuroblastoma is the most common cancer found in […]

Osteoporosis – Medical Marijuana Research Overview

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Affecting more than 53 million people in the […]

cerebral palsy and cannabis

Medical Marijuana, Inc. Is Proud to Support World Multiple Sclerosis Day to Help Raise Awareness

Medical Marijuana, Inc. would like to stop for a moment today to recognize World MS Day 2017 and the more than 2.3 million people currently suffering from multiple sclerosis around the world. According to the World MS Day website, “World MS Day is officially marked on the last Wednesday of May. It brings the global […]

Post Laminectomy Syndrome – Medical Marijuana Research Overview

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Post laminectomy syndrome is persistent pain that develops […]

Cystic Fibrosis – Medical Marijuana Research Overview

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Cystic fibrosis is a life-threatening genetic disorder that […]

cerebral palsy and cannabis

Cerebral Palsy – Medical Marijuana Research Overview

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Cerebral palsy is a term used to categorize […]

Huntington’s Disease – Medical Marijuana Research Overview

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Huntington’s disease is a fatal genetic disorder in […]

HempMeds® and CBD Receive Major News Coverage in Pittsburgh

Medical Marijuana, Inc. portfolio company HempMeds® just returned from Pittsburgh, Pennsylvania, where the company participated in the World Medical Cannabis Conference and Expo this past weekend. Hosted from Friday to Saturday, April 21-22, the event attracted medical marijuana patients and cannabis industry insiders and activists to the David L. Lawrence Convention Center in downtown Pittsburgh [...]

Blake Schroeder Shares Outlook on Future of Medical Marijuana with CBS Pittsburgh

Medical Marijuana, Inc. VP of Operations and CEO of Kannaway Blake Schroeder appeared on CBS Pittsburgh radio with host Robert Mangino, ahead of Medical Marijuana, Inc.’s appearance at the World Medical Cannabis Conference and Expo this weekend. Blake touches on medical cannabis research, how the Trump administration may affect the cannabis industry, and more. Our […]

AXIM® Biotechnologies to Develop Chewing Gum with Bioequivalence to Marinol®

AXIM® Biotechnologies, a major Medical Marijuana, Inc. investment company, has taken the first steps toward developing a chewing gum bioequivalent to Marinol, made using a synthetic version of THC or tetrahydrocannabinol. This week, AXIM® Biotechnologies revealed that it entered into a Term Sheet Agreement with a U.S.-based Active Pharmaceutical Ingredient (API) production company. Through this [...]